Supramed Logo

1. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.
2. Barlow DH, Brockie JA, Rees CM. Study of general practice consultations and menopausal problems. Oxford General Practitioners Menopause Study Group. BMJ 1991; 302: 274-276.
3. Rekers H. Mastering the Menopause. In: Burger , Boulet (eds). A Potrait of the Menopause. The Parthenon Publishing Group, New Jersey, USA: 1991; 23-43.
4. Ismael NN. A study on the menopause in Malaysia. Maturitas 1994; 19: 205-209.
5. Tang GW. The climacteric of Chinese factory workers. Maturitas 1994; 19:177-182.
6. Boulet MJ, Oddens BJ, Lehert P, et al. Climacteric and menopause in seven South-east Asian countries. Maturitas 1994;19:157-176.
7. Collins BM, McLachlan JA, Arnold SF. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. Steroids 1997; 62: 365-372.
8. Price KR, Fenwick GR. Naturally occurring oestrogens in foods - a review. Food Addit Contam 1985; 2: 73-106.9. Dewick PM. In: The Flavonoids: Advances in Research since 1986. Harborne JB, ed. Chapman and Hall, London: 1994; p117.10. Tahara S, Ibrahim RK. Prenylated isoflavonoids - an update. Phytochemistry 1995; 38:1073-1094.
11. Couse JF, Lindzey J, Grandien K, et al. Tissue distribution and quantitative analysis of estrogen receptor-b (ERa) and estrogen receptor-b (ERb) messenger ribonucleic acid in the wild-type and ERb-knockout mouse. Endocrinol1997; 138:4613-4621.26. Miksicek RJ. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 1995; 208: 44-50.
12.Cato AC, Miksicek R, Schutz G, et al. The hormonal regulatory element of mouse mammary tumor virus mediates progesterone induction. EMBO J 1986; 5: 2237-2240.
13.Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vase Biol 1997; 17: 2524-2531.
14. Potter SM. Soy protein and cardiovascular disease: The impact of bioactive components in soy. Nutr Rev 1998; 56: 231-235.
15. Di Salvo J, Pfitzer G, Semenchuk LA. Protein tyrosine phosphorylation, cellular Ca2+, and Ca2+ sensitivity for contraction of smooth muscle. Can J Physiol Pharmacol 1994; 72:1434-1439.16. Rizzo MT, Weber G. 1-Phosphotidylinositol 4-kinase: an enzyme linked with proliferation and malignancy. Cancer Res 1994:54:2611-2614.
17. Blair HC, Jordan SE, Peterson TG, et al. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomised rats. J Cell Biochem 1996; 61: 629-637.18. S.A.Binggham, C. Atkinson, J. Liggins, L. Bluck und A. Coward, 18. ,,Phyto-oestrogens: where are we now?". British Journal of Nitrition, Vol 79, S.393-406, 1998
19.D. C. Knight.FRACOG, und J. A. Eden, FRACOG, A Review of the Clinical Effekts of Phytoestrogens. Obstetrics and Gynecology. Vol 87,S. 897-904, 199620. M. S. Kurzer and X. Xu, Dietray phytoestrogens. Annual Review of Nutrition, Vol 17, S. 353-381, 1997

20. Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: A systematic review and meta-analysis. Maturitas 2006; 55(3):203-211.

22.Cassidy A. Committee on Toxicity draft report on phyto-oestrogens and health – review of proposed health effects of phyto-oestrogen exposure and recommendations for future research, Nutrition Bulletin 2003; 28:205–213.

23.Cassidy A, et al. Critical review of health effects of soyabean phyto-oestrogens in postmenopausal women. Proc of the Nutr Soc 2006; 65:76-92.

24. Consensus Opinion 2000. The role of isoflavones in menopausal health: Consensus opinion of the North American Menopause Society. Menopause 2000;7:215-229.
25. Krebs EE, et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104:824-836.

26. Messina, M. and Hughes, C. Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J.Med. Food 2003; 6:1-11.

27. Position statement of the North American Menopause Society; treatment of menopauseassociated vasomotor symptoms. Menopause 2004; 11(1):11-33.
28. Rhodes M, Price KR. Phytochemicals. In Encyclopedia of Human Nutrition 1999, p. 1543-1544. Academic Press, UK.

29. Rohr U. Soja und Rotklee. Phytoestrogene in der Prävention. Konsensustreffen, Wien. Pharmazeutische Zeitung 2004;45:20-30.

Kuiper G, Lemmen J, Carlsson BO et al. Interaction of estrogen chemical and phytoestrogen with estrogen receptor ß . Endocrinology 1998, 39:4552-4563.

44. Markiewicz L, Garey J, Adlercruetz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993; 45:399-405.

45. Nagata, C., Takatsuka, N., Kawakami, N. & Shimizu, H. Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am. J. Epidemiol. 2001; 153:790-793.

46. Scambia, G., Mango, D., Signorile, P. G., Angeli, R. A., Palena, C., Gallo, D., Bombardelli, E., Morazzoni, P., Riva, A. & Mancuso, S. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000; 7:105-111. 47. Upmalis, D. H., Lobo, R., Bradley, L., Warren, M., Cone, F. L. & Lamia, C. A. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo- controlled study. Menopause 2000; 7: 236-242.

48. Washburn, S., Burke, G. L., Morgan, T. & Anthony, M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6:7-13.

49. Nagata C, Takatsuka N, Kurisu Y & Shimizu H, Decreased total serum cholesterol concentration is associated with high intake of soy products in Japanese Men and women. J Nutr 1998; 128:209-213.

50. MaDF, Qin LQ, Wang PY, Katoh R. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials. Eur J Clin Nutr 2007.
51. Albertazzi P et al. (2002) The nature and utility of the phytoestrogens: a review of the evidence. Maturitas, 42, 173-185.
52. Cassidy A (2003) Committee on Toxicity draft report on phyto-oestrogens and health – review of proposed health effects of phyto-oestrogen exposure and recommendations for future research, Nutrition Bulletin, 28: 205–213.

53. Messina M,Suzanne Ho and Lee Alekel. Skeletal benefits of soy isoflavones : a review of the clinical trial and epidemiologic data. Current Opinion in clinical Nutrition and Metabolic Care 2004,7: 649-658

54. Migliaccio S et al (2003) Isoflavones and skeletal health: are these molecules ready for clinical application?Review. Osteoporosis International, 14: 361 - 368.

55.Setchell K, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone : evidence from in vitro and in vivo, human observational and dietary intervention study.Am J Clin Nutr 2003;78(suppl):593S-609S

56.Alekel DL, St.Germain A, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844-852, 2000.

57. Breslau NA, Brinkley L, Hill KD, Pak CYC. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metabol 66:140-146, 1988.

58. Chen YM, et al. (2004) Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial. Menopause, 11:246-254.

59. Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, Ayton R, Strauss BJG. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1:124-129, 1998.

60.Duncan AM, et al. (2003) Phyto-oestrogens. Best Pract Res Clin Endocr Metab, 17: 253-271.

61. Harkness LS, et al. (2004) Decreased bone resorption with soy isoflavone supplementation in postmenopausal women. J Women’s Health, 13: 1000-1007.

62. Ho SC, Chan SG, Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res. 2001 Jul;16(7):1363-9.

63. Ho SC,WooJ,LAm S,Chen Y,Sham A,LauJ . Soy protein consumption and bone mass in early postmenopausal Chinese women. .Osteoporos Int. 2003 Oct;14(10):835-42.

64. Huang HY, Yang HP, Yang HT, Yang TC, Shieh MJ, Huang SY. One-year soy isoflavone supplementation prevents early postmenopausal bone loss but without a dose-dependent effect. J Nutr Biochem 2006; 17:509-17.

66. Lydeking-Olsen E, Beck-Jensen J-E, Setchell KDR, Holm-Jensen T. Soymilk or progesterone for prevention of bone loss: A 2 year randomized, placebo-controlled trial. Eur J Nutr 43:246- 257, 2004.

67. Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo MA, Cincotta M, Altavilla D, Ientile R, Squadrito F. Effects of genistein and hormonereplacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.J Bone Miner Res. 2002 Oct;17(10):1904-12.
68. Newton KM, Lacroix AZ, Levy L et al. Soy protein and bone mineral density in older men and women: A randomized trial. Maturitas 2006.

69. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S-1379S, 1998.

70 Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97:109-115, 2001.
71 Squadrito F et al. Effects of the phytoestrogen genistein on bone loss,cardiovascular risk prevention and climacteric symptoms: a two year double blind placebo controlled study. Interim evaluation at one year. Oral presentation and abstract 6th Int symposium on the role of soy in preventing and treating chronic diseases Nov2005

72. Uesugi T, et al (2002) Beneficial Effects of Soybean Isoflavone Supplementation on Bone Metabolism and Serum Lipids in Postmenopausal Japanese Women: A Four-Week Study. Journal of the American College of Nutrition, 21: 97–102.

73.Zhang X, Shu XO, Li H, Yang G, Li Q, Gao YT, Zheng W. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women.Arch Intern Med. 2005 Sep 12;165(16):1890-5.

74. Ye YB, Tang XY, Verbruggen MA, Su YX. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women : A single-blind randomized, placebo-controlled trial. Eur J Nutr 2006.

75. Choi, S. Y., Ha, T. Y., Ahn, J. Y., Kim, S. R., Kang, K. S., Hwang, I. K., und Kim, S. (2008). Estrogenic Activities of Isoflavones and Flavones and their Structure-Activity Relationships. Planta Med 74 (1): 25-32.76. D'Anna, R., Cannata, M. L., Atteritano, M., Cancellieri, F., Corrado, F., Baviera, G., Triolo, O., Antico, F., Gaudio, A., Frisina, N., Bitto, A., Polito, F., Minutoli, L., Altavilla, D., Marini, H., und Squadrito, F. (2007). Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause 14 (4): 648-655.

77. Duffy, C., Perez, K., und Partridge, A. (2007). Implications of phytoestrogen intake for breast cancer. CA Cancer J. Clin 57 (5): 260-277.

78. Gruber, C. J., Tschugguel, W., Schneeberger, C., und Huber, J. C. (2002). Production and actions of estrogens. N. Engl. J. Med 346 (5): 340-352.

79. Guerini, V., Sau, D., Scaccianoce, E., Rusmini, P., Ciana, P., Maggi, A., Martini, P. G., Katzenellenbogen, B. S., Martini, L., Motta, M., und Poletti, A. (2005). The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res. 65 (12): 5445-5453.

80. Handa, R. J., Pak, T. R., Kudwa, A. E., Lund, T. D., und Hinds, L. (2008). An alternate pathway for androgen regulation of brain function: Activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. Horm. Behav. 53 (5): 741-752.

90. Harris, D. M., Besselink, E., Henning, S. M., Go, V. L., und Heber, D. (2005). Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp. Biol. Med (Maywood. ) 230 (8): 558-568.

91. Harris, H. A. (2006). Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential. Ernst. Schering. Found. Symp. Proc 1: 149-161.

92. Harris, H. A. (2007). Estrogen receptor-beta: recent lessons from in vivo studies. Mol. Endocrinol. 21 (1): 1-13.

93. Heldring, N., Pike, A., Andersson, S., Matthews, J., Cheng, G., Hartman, J., Tujague, M., Strom, A., Treuter, E., Warner, M., und Gustafsson, J. A. (2007). Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 87 (3): 905-931.

94. Ikeda, Y., Iki, M., Morita, A., Kajita, E., Kagamimori, S., Kagawa, Y., und Yoneshima, H. (2006). Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J. Nutr. 136 (5): 1323-1328.

95. Kobayashi, S. (1992). Trends in national nutritional survey of Japan. Nutr. Health 8 (2-3): 91-96.

96. Koehler, K. F., Helguero, L. A., Haldosen, L. A., Warner, M., und Gustafsson, J. A. (2005). Reflections on the discovery and significance of estrogen receptor beta. Endocr. Rev. 26 (3): 465-478.

97. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., und Gustafsson, J. A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (3): 863-870.
98. Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der, Burg B., und Gustafsson, J. A. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (10): 4252-4263.

99. Kulling, S. E. und Watzl, B. (2003). Phytoöstrogene. Ernährungs-Umschau 50: 234-239. PDF

100. Lee, M. M., Gomez, S. L., Chang, J. S., Wey, M., Wang, R. T., und Hsing, A. W. (2003). Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol. Biomarkers Prev. 12 (7): 665-668.
101. McCarty, M. F. (2006). Isoflavones made simple - Genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. Med. Hypotheses 66 (6): 1093-1114.

102. Mishra, R. G., Stanczyk, F. Z., Burry, K. A., Oparil, S., Katzenellenbogen, B. S., Nealen, M. L., Katzenellenbogen, J. A., und Hermsmeyer, R. K. (2006). Metabolite ligands of estrogen receptor-beta reduce primate coronary hyperreactivity. Am J. Physiol Heart Circ. Physiol 290 (1): H295-H303.

103. Nagata, C., Takatsuka, N., Kawakami, N., und Shimizu, H. (2001). Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J. Epidemiol. 153 (8): 790-793.

104. Niculescu, M. D., Pop, E. A., Fischer, L. M., und Zeisel, S. H. (2007). Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J. Nutr. Biochem. 18 (6): 380-390.

105. Pop, E. A., Fischer, L. M., Coan, A. D., Gitzinger, M., Nakamura, J., und Zeisel, S. H. (2008). Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial. Menopause 15 (4): 684-692.

106. Remer, T., Boye, K. R., Hartmann, M. F., und Wudy, S. A. (2005). Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J. Clin Endocrinol. Metab 90 (4): 2015-2021.

107. Sarkar, F. H., Adsule, S., Padhye, S., Kulkarni, S., und Li, Y. (2006). The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. Mini. Rev. Med Chem. 6 (4): 401-407.

108. Wuttke, W., Jarry, H., und Seidlova-Wuttke, D. (2007). Isoflavones - safe food additives or dangerous drugs? Ageing Res. Rev. 6 (2): 150-188.

109. Yang, G., Shu, X. O., Jin, F., Zhang, X., Li, H. L., Li, Q., Gao, Y. T., und Zheng, W. (2005). Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J. Clin Nutr. 81 (5): 1012-1017.

110. Zhang, X., Shu, X. O., Gao, Y. T., Yang, G., Li, Q., Li, H., Jin, F., und Zheng, W. (2003). Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J. Nutr. 133 (9): 2874-2878.

111. Zhang, X., Shu, X. O., Li, H., Yang, G., Li, Q., Gao, Y. T., und Zheng, W. (2005). Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch. Intern. Med. 165 (16): 1890-1895.

112. Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.Carlson S, Peng N, Prasain JK, Wyss JM.

Wollen Sie selbst mal nachschauen, was die Wissenschaft über Isoflavone sagt?